Scharff P - Search Results

1

Scharff P, Ritter U, Matyshevska OP, Prylutska SV, Grynyuk II, Golub AA, Prylutskyy YI, Burlaka AP. Scharff P, et al. Tumori. 2008 Mar-Apr;94(2):278-83. doi: 10.1177/030089160809400221. Tumori. 2008. PMID: 18564617

2

Catalytic system of the reactive oxygen species on the C60 fullerene basis.

Burlaka AP, Sidorik YP, Prylutska SV, Matyshevska OP, Golub OA, Prylutskyy YI, Scharff P. Burlaka AP, et al. Among authors: scharff p. Exp Oncol. 2004 Dec;26(4):326-7. Exp Oncol. 2004. PMID: 15627068

3

Effect of the visible light irradiation of fullerene-containing composites on the ROS generation and the viability of tumor cells.

Prylutska SV, Burlaka AP, Matyshevska OP, Golub AA, Potebnya GP, Prylutskyy YI, Ritter U, Scharff P. Prylutska SV, et al. Among authors: scharff p. Exp Oncol. 2006 Jun;28(2):160-2. Exp Oncol. 2006. PMID: 16837910

4

Hyperthermic effect of multi-walled carbon nanotubes stimulated with near infrared irradiation for anticancer therapy: in vitro studies.

Burlaka A, Lukin S, Prylutska S, Remeniak O, Prylutskyy Y, Shuba M, Maksimenko S, Ritter U, Scharff P. Burlaka A, et al. Among authors: scharff p. Exp Oncol. 2010 Mar;32(1):48-50. Exp Oncol. 2010. PMID: 20332757

5

Pristine C(60) fullerenes inhibit the rate of tumor growth and metastasis.

Prylutska SV, Burlaka AP, Prylutskyy YI, Ritter U, Scharff P. Prylutska SV, et al. Among authors: scharff p. Exp Oncol. 2011 Sep;33(3):162-4. Exp Oncol. 2011. PMID: 21956470

6

Effect of fullerene C60 on ATPase activity and superprecipitation of skeletal muscle actomyosin.

Andreichenko KS, Prylutska SV, Medynska KO, Bogutska KI, Nurishchenko NE, Prylutskyy YI, Ritter U, Scharff P. Andreichenko KS, et al. Among authors: scharff p. Ukr Biokhim Zh (1999). 2013 Mar-Apr;85(2):20-6. Ukr Biokhim Zh (1999). 2013. PMID: 23808306

7

Effect of iron-doped multi-walled carbon nanotubes on lipid model and cellular plasma membranes.

Prylutska S, Bilyy R, Schkandina T, Bychko A, Cherepanov V, Andreichenko K, Stoika R, Rybalchenko V, Prylutskyy Y, Scharff P, Ritter U. Prylutska S, et al. Among authors: scharff p. Mater Sci Eng C Mater Biol Appl. 2012 Aug 1;32(6):1486-9. doi: 10.1016/j.msec.2012.04.029. Epub 2012 Apr 24. Mater Sci Eng C Mater Biol Appl. 2012. PMID: 24364949

8

C60 fullerene as synergistic agent in tumor-inhibitory Doxorubicin treatment.

Prylutska S, Grynyuk I, Matyshevska O, Prylutskyy Y, Evstigneev M, Scharff P, Ritter U. Prylutska S, et al. Among authors: scharff p. Drugs R D. 2014 Dec;14(4):333-40. doi: 10.1007/s40268-014-0074-4. Drugs R D. 2014. PMID: 25504158 Free PMC article.

9

C60 fullerene prevents genotoxic effects of doxorubicin in human lymphocytes in vitro.

Afanasieva KS, Prylutska SV, Lozovik AV, Bogutska KI, Sivolob AV, Prylutskyy YI, Ritter U, Scharff P. Afanasieva KS, et al. Among authors: scharff p. Ukr Biochem J. 2015 Jan-Feb;87(1):91-8. Ukr Biochem J. 2015. PMID: 26036135

10

Application of C60 Fullerene-Doxorubicin Complex for Tumor Cell Treatment In Vitro and In Vivo.

Panchuk RR, Prylutska SV, Chumakl VV, Skorokhyd NR, Lehka LV, Evstigneev MP, Prylutskyy YI, Berger W, Heffeter P, Scharff P, Ritter U, Stoika RS. Panchuk RR, et al. Among authors: scharff p. J Biomed Nanotechnol. 2015 Jul;11(7):1139-52. doi: 10.1166/jbn.2015.2058. J Biomed Nanotechnol. 2015. PMID: 26307837

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters